Medicare & ACA in 2026: The $2,100 Drug Cap, Expired Subsidies, and What It Means for South Florida Families

Marie, a widow living in Hollywood, used to dread January. Every year she would stare at the deductible reset on her Cigna Part D plan, do the math on her arthritis, diabetes, and heart medications, and realize she was looking at four-figure out-of-pocket costs before she’d even seen her first doctor of the new year. In a bad year, she spent close to $6,000 just at the pharmacy counter.

This year, Marie’s worst-case scenario is capped at $2,100 — by federal law.¹

That single change — one number written into federal law by the Inflation Reduction Act and fully phased in this January — is the biggest financial relief for older Americans in a generation. And it landed alongside two more shifts that are reshaping health coverage in 2026: the first wave of Medicare-negotiated drug prices,² and the expiration of the enhanced ACA subsidies that had kept Marketplace plans affordable for tens of millions of working-age families.³

South Florida is unusually exposed to all of this. Florida has roughly 5.1 million Medicare beneficiaries — second only to California — with one of the highest Medicare Advantage penetration rates in the country.⁴ And Florida leads the nation in ACA Marketplace enrollment, with 4,735,415 Floridians on Marketplace plans for 2025.⁵ What happens in Washington this year shows up at Florida pharmacy counters and kitchen tables faster than almost anywhere else.

1. What changed on January 1, 2026

The Inflation Reduction Act of 2022 wasn’t a single switch — it was a multi-year staircase, with the biggest changes phasing in over four years. 2026 is the year the staircase tops out.

To understand what’s different now, it helps to remember what came before. For decades, Medicare Part D had no annual out-of-pocket maximum. Beneficiaries with high-cost prescriptions paid into a multi-stage cost-sharing system: a deductible, then a coverage phase, then a notorious “doughnut hole” coverage gap, then catastrophic coverage where the beneficiary still paid 5% of drug costs — unlimited. For Medicare beneficiaries on cancer therapies or biologics, that 5% could easily add up to $8,000, $12,000, or more per year. The IRA closed all of it: the doughnut hole, the 5% catastrophic share, and the missing annual ceiling.

Three major provisions are now fully live in 2026:

2. The $2,100 Part D out-of-pocket cap, in plain English

For four decades, Medicare prescription drug coverage had a structural problem every beneficiary eventually learned about the hard way: there was no annual out-of-pocket limit. You could spend $500. You could also spend $5,000, or $15,000, depending on what your doctor prescribed and what tier your plan put it on. The infamous “doughnut hole” was partially closed over the years, but a true ceiling didn’t exist.

Starting in 2025, the IRA capped annual out-of-pocket Part D spending at $2,000. Starting in 2026, that cap is indexed each year by the average growth in Part D drug expenditures — pushing the 2026 ceiling to $2,100.¹ Once you hit it, your plan pays 100% of your covered drug costs for the rest of the calendar year.

“A hard ceiling is the single most important financial change in Medicare in a generation. For the first time, drug costs have a top.”

In practical terms, the cap is most life-changing for beneficiaries with high-cost specialty drugs — cancer therapies, anticoagulants, biologics for autoimmune conditions. For someone whose oncologist prescribes a $14,000-a-month chemotherapy pill, the math has gone from “impossible to afford” to “$2,100 a year out-of-pocket.” According to KFF analysis, about 1.4 million Medicare beneficiaries hit catastrophic-phase spending in a typical year — all of them now face a defined ceiling instead of an open-ended bill.

3. Ten drugs, real savings — the first Medicare-negotiated prices

Separate from the cap, 2026 is the first calendar year in which Medicare-negotiated drug prices are actually in effect at the pharmacy counter. After decades of prohibition, the IRA authorized Medicare to negotiate prices on a rolling list of the costliest, most-prescribed Part D drugs — ten in this first round, with more added in 2027, 2028, and beyond. The first ten Maximum Fair Prices (MFPs) took effect January 1, 2026.²

Eight of the ten target chronic conditions that are heavily represented in South Florida’s senior population — diabetes, heart failure, atrial fibrillation, and autoimmune disease. Florida is also one of the highest-prescribing states for several of these drugs, which means the negotiated prices translate into real dollars at local Walgreens, CVS, Publix, and Sedano’s pharmacy counters every day this year.

The way the negotiation worked is worth understanding because more rounds are coming. CMS issued the initial offer to each manufacturer, the manufacturer countered, and the two sides exchanged offers and counter-offers under a statutorily defined framework that weighed clinical benefit, comparator drugs, and federal financial assistance the manufacturer had received during the drug’s development. The final Maximum Fair Price is the price Medicare Part D plans pay the manufacturer going forward — not necessarily the price the beneficiary sees at the pharmacy, which still depends on plan copay structure, formulary tier, and the new cost-sharing math in the IRA’s redesigned benefit. Round two of negotiation, announced in early 2025, will set MFPs effective in 2027 for a new batch of drugs — including, notably, several semaglutide products commonly used for diabetes and weight management.

4. Insulin: still $35 a month, period

Separately from the new cap and the negotiated prices, the IRA’s $35-per-month insulin cap remains in force for every Medicare beneficiary in 2026. This isn’t new — it’s been the rule since 2023 — but it’s worth restating because diabetes is one of the most common conditions among South Florida seniors, and the cap continues to save eligible beneficiaries hundreds of dollars per month.

Technically the rule is “the lesser of $35, 25% of the Maximum Fair Price, or 25% of the negotiated price.” In practice, for the major insulin products covered by Medicare, the cost at the counter is $35 or less per one-month supply — with no deductible to satisfy first and no coinsurance after.

5. The Medicare Prescription Payment Plan (M3P)

A change that is often overlooked: as of 2025, every Part D enrollee can opt into the Medicare Prescription Payment Plan — sometimes called M3P or “smoothing.” Instead of paying a large lump sum the month you fill an expensive prescription, your plan spreads your out-of-pocket Part D costs across the remaining months of the calendar year in equal monthly bills.

The total you pay is the same. What changes is the cash-flow predictability. This is especially helpful in three situations:

• You hit the $2,100 cap early in the year — for example, a January prescription for a specialty drug. Without M3P, you’d pay $2,100 in January and zero the rest of the year. With M3P, you’d pay roughly $175 a month for the rest of the year.
• You’re on a fixed Social Security budget and a $300 or $500 refill in any given month would crowd out groceries or rent.
• You’re new to Medicare and not sure how the deductible / initial-coverage / catastrophic phases work in your specific plan.

M3P is opt-in. You have to elect it — either when you join a plan or any time during the year — and you can also opt out. The Medicare.gov walkthrough has the official mechanics. We help our clients figure out whether smoothing makes sense given their specific prescription pattern and household budget.

6. The ACA subsidy cliff: a kitchen-table problem for working-age families

Everything above is for the Medicare-eligible — broadly, age 65 and over, or under 65 with a qualifying disability. For working-age South Floridians, 2026’s biggest news isn’t a benefit that arrived — it’s a benefit that left.

Background: in 2021, the American Rescue Plan Act and then the Inflation Reduction Act expanded the ACA’s Premium Tax Credits in two important ways. First, they eliminated the so-called “400% subsidy cliff” — meaning households above 400% of the federal poverty level could now qualify for subsidies if their benchmark plan would otherwise cost more than 8.5% of income. Second, they sweetened the formula for everyone else, lowering the share of income any household has to pay toward the benchmark Silver plan.

Those enhanced subsidies expired on January 1, 2026.³ Congress hasn’t yet passed a replacement, so the Marketplace formula reverted to its pre-2021 baseline. The kitchen-table effect, by the numbers:

For a self-employed contractor in Pompano Beach making $55,000 who was paying near-$0 a month for a Silver plan in 2025, the 2026 reset means a monthly premium jump in the $200–$400 range. For a family of four in Sunrise, the change is typically a few thousand dollars a year. Many households — particularly those just over 400% of the federal poverty level, where the so-called “subsidy cliff” reappears post-expiration — have seen the biggest jumps.

“The single biggest variable for working-age South Florida families this year isn’t a new benefit — it’s whether a benefit they already had is still around for next year’s Open Enrollment.”

7. What this looks like in South Florida

Zoom in on Broward County and a few patterns matter:

• Florida has roughly 5.1 million Medicare beneficiaries — second only to California — with a Medicare Advantage penetration rate of about 60%, well above the national average.⁴ Three out of five Florida Medicare beneficiaries are in a Medicare Advantage plan, which means the formulary on those plans — and how each plan treats the ten negotiated drugs — is the deciding factor for most Floridians. MA penetration is especially high in our service area; Miami-Dade tops out around 80%.
• The dominant Medicare Advantage carriers in Broward are Humana, UnitedHealthcare, Aetna, Cigna, Florida Blue (BCBS), and WellCare, with smaller market-share players like Devoted Health and CarePlus active in several ZIPs. Each carrier’s network around Memorial Healthcare, Broward Health, Holy Cross, HCA Florida, and Cleveland Clinic Florida differs — we verify your specific doctors and specialists before quoting.
• Cities with the highest senior populations in our service area include Hollywood, Pompano Beach, Pembroke Pines, Lauderhill, and Coral Springs — see our city-specific pages for Hollywood and Pompano Beach.
• Florida leads the nation in ACA Marketplace enrollment — 4,735,415 Floridians had a Marketplace plan during the 2025 Open Enrollment Period.⁵ That’s roughly one in four Floridians under 65 who rely directly on Marketplace plans, the vast majority with subsidies.
• Haitian Creole and French speakers make up a meaningful slice of our local Medicare and ACA population — nuance in plan documents matters, and English-only enrollment leaves money on the table. Every JCKC appointment can be conducted in English, Kreyòl Ayisyen, or Français.

8. Enrollment windows that matter in 2026

Whether you’re on Medicare or on a Marketplace plan, the calendar matters. Miss a window and you may pay a lifetime penalty or wait a year for the next opportunity. Here’s the cheat sheet for South Florida households this year:

9. Your 2026 action plan

Whether you’re on Medicare or on a Marketplace plan, the next twelve months will reward families who plan ahead instead of waiting for the open-enrollment mail to arrive. Here’s the plain checklist:

If you’re on Medicare:

1. Review your Part D formulary now. Some plans changed dramatically after the IRA redesign. We can pull the formulary against your actual prescription list and tell you, in five minutes, whether you’re paying more than you need to.
2. Mark your Annual Enrollment Period: October 15 – December 7, 2026. That’s your annual window to switch Medicare Advantage plans, change Part D, or move to or from Original Medicare. Changes take effect January 1, 2027.
3. If you’re turning 65 in the next 7 months, your Initial Enrollment Period starts three months before your birthday month. Late enrollment in Part B or Part D triggers lifetime penalties — this is the single appointment we don’t recommend deferring.
4. Consider the M3P. If a single month’s drug bill has ever landed harder than you expected, smoothing your payments is probably worth a five-minute conversation.

If you’re on an ACA Marketplace plan:

1. Recalculate now if you haven’t. The enhanced subsidies expired January 1, 2026. Your 2026 premium may already be higher than you realized. We’ll pull your specific household’s subsidy under the current (pre-2021) formula in five minutes so you know exactly where you stand.
2. Watch Congress. The House passed a three-year subsidy extension and the Senate is considering its own version. If the enhanced credits are restored mid-year, the Marketplace will retroactively adjust eligible households — but you’ll need an up-to-date application on file to benefit.
3. Update your income estimate. If your 2026 income looks different from what’s on file with the Marketplace, update it — you don’t want to discover a reconciliation surprise at tax time.
4. Open Enrollment for plan year 2027 runs November 1, 2026 – January 15, 2027. We re-shop our clients every year.
5. If you’ve had a qualifying life event — a new baby, a marriage, a move, loss of employer coverage — you have a 60-day Special Enrollment Period right now to make changes.

10. Frequently asked questions

What we’ll do for you

JCKC Financial Services is an independent insurance brokerage based in Broward County. We’re paid by the carriers at a standardized rate, regardless of which plan you pick — which means our recommendation is shaped by your needs, your doctors, and your medications, not by what we’re paid to sell. We work in English, Kreyòl Ayisyen, and Français, and every plan review is free.

If you’re on Medicare, we’ll pull every Part D plan available in your ZIP code, match it against your specific medication list (including which tier each of the ten negotiated drugs sits on for that plan), verify your doctors and specialists are in-network, and walk you through the trade-offs side-by-side. You pick. We never do.

If you’re on an ACA Marketplace plan, we’ll calculate your exact 2026 subsidy under the current (post-expiration) formula — and we’ll keep a watch on the Congressional action so we can re-quote you the moment any extension passes. We’ll handle the application, verify your providers are in-network, and stay on the phone with you through the carrier handoff.

Either way, a free fifteen-minute conversation is usually enough to know what’s possible. Schedule a call or pick up the phone — (954) 825-9923.

11. Sources

1. Centers for Medicare & Medicaid Services. Final CY 2026 Part D Redesign Program Instructions Fact Sheet. April 2025. cms.gov/newsroom/fact-sheets/final-cy-2026-part-d-redesign-program-instructions
2. U.S. Department of Health and Human Services. HHS Announces New Prices for First Ten Drugs in Medicare Drug Price Negotiation. August 15, 2024. cms.gov/newsroom/press-releases/hhs-announces-new-prices-first-ten-drugs-medicare-price-negotiation
3. Kaiser Family Foundation. Inflation Reduction Act Health Insurance Subsidies: Impact and Expiration Scenarios. July 2024. kff.org/affordable-care-act/issue-brief
4. Kaiser Family Foundation. Medicare Advantage in 2024: Enrollment Update and Key Trends. kff.org/medicare/medicare-advantage-in-2024-enrollment-update-and-key-trends
5. Centers for Medicare & Medicaid Services. Over 24 Million Consumers Selected Affordable Health Coverage in 2025 ACA Marketplace Open Enrollment Period. January 2025. cms.gov/newsroom/press-releases/over-24-million-consumers-selected-affordable-health-coverage-aca-marketplace-2025
6. Medicare.gov. What’s the Medicare Prescription Payment Plan? medicare.gov/health-drug-plans/part-d/costs/payment-plan
7. Kaiser Family Foundation. Medicare Part D: A First Look at Plans in 2026. kff.org/medicare/issue-brief/medicare-part-d-a-first-look-at-medicare-prescription-drug-plans-in-2026
8. Congressional Budget Office. The Effects of Not Extending the Expanded Premium Tax Credits. cbo.gov/publication/61149

Disclaimer: JCKC Financial Services is a private licensed insurance brokerage. We are not connected with or endorsed by the United States government, the federal Medicare program, or any state agency. Insurance plan availability, pricing, and terms vary by carrier, ZIP code, and individual circumstances. This article is for general information only and is not a substitute for personalized advice from a licensed insurance broker.